secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001213900-23-049894
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics shareholders approve reverse stock split, elect directors at annual meeting
--------------------------------------------------------------------------------

- Elected six directors: Wurth, N. Dey, S. Dey, Chase, Zeidman, Gemignani; each received >10.6M votes for.
- Approved amendment to certificate of incorporation to effect reverse stock split; 12.79M for, 714k against.
- Ratified Wolf & Company, P.C. as independent auditor for FY 2023; 13.38M for, 88k against.
- Quorum of 67.2% (13.75M shares) present at meeting held June 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023049894/0001213900-23-049894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023049894/ea180616-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-049894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer